Literature DB >> 33542126

Modulating gut microbiota to treat cancer.

Christopher H Woelk1, Alexandra Snyder2.   

Abstract

Entities:  

Year:  2021        PMID： 33542126     DOI： 10.1126/science.abg2904

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  4 in total

1.  Alterations of the Gut Microbiome in Recurrent Malignant Gliomas Patients Received Bevacizumab and Temozolomide Combination Treatment and Temozolomide Monotherapy.

Authors:  Junwei Zhu; Jun Su
Journal:  Indian J Microbiol       Date:  2021-07-03       Impact factor: 2.461

Review 2.  The Role of Gut Microbiota in Tumor Immunotherapy.

Authors:  Miao Wu; Jiawei Bai; Chengtai Ma; Jie Wei; Xianjin Du
Journal:  J Immunol Res       Date:  2021-08-26       Impact factor: 4.818

Review 3.  Gut Microbiota as Potential Biomarker and/or Therapeutic Target to Improve the Management of Cancer: Focus on Colibactin-Producing Escherichia coli in Colorectal Cancer.

Authors:  Julie Veziant; Romain Villéger; Nicolas Barnich; Mathilde Bonnet
Journal:  Cancers (Basel)       Date:  2021-05-05       Impact factor: 6.639

Review 4.  Cancer pharmacomicrobiomics: targeting microbiota to optimise cancer therapy outcomes.

Authors:  Nick Lung-Ngai Ting; Harry Cheuk-Hay Lau; Jun Yu
Journal:  Gut       Date:  2022-03-11       Impact factor: 31.793
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.